Sunday, September 20, 2020

Can COVID-19 Infection Result In Diabetes?

A new report has found that the COVID-19 infection can cause sudden onset insulin-dependent diabetes. The report details a case of a 19-year-old young German man, who had no symptoms of COVID-19 but test positive for it, developed type 1 diabetes after a few weeks.

Study Discovers How Activated Human Brown Fat Could Help Treat Obesity and Diabetes

A new study has found that how humans can activate brown fat, which may help treat obesity and type 2 diabetes. The study researchers discovered a specific type of receptor in human brown fat cells that when activated could help treat obesity and diabetes.

FDA Approves Abbott’s FreeStyle Libre 2, A Continuous Glucose Monitoring System

Abbott Laboratories announced Monday that it got FDA clearance for its integrated continuous glucose monitoring system called FreeStyle Libre 2 for diabetic patients so they can monitor their glucose levels regularly. FreeStyle Libre 2 can monitor your blood sugar almost every minute.

Beta Cell Replacement Therapy Could Cure Type 1 Diabetes, Study

A new study has found that in vitro generated beta cells can be used as potential replacement therapy for patients with type 1 diabetes. Researchers developed a specialized stem-cell-derived beta cell that can be transplanted in diabetics so they can keep their blood sugar under control.

FDA Has No Plans to Recall Diabetes Drug Metformin

The US Food and Drug Administration (FDA) said it has no plans to recall metformin, a diabetes drug, after it failed to show any evidence of contamination with a carcinogen called N-nitrosodimethylamine (NDMA). The FDA said it would continue monitoring NDMA in metformin medications.

VA Department and Virta Health Focus On Reversing Diabetes with Keto Diet

The US Department of Veterans Affairs collaborated with a startup company called Virta Health to focus their attention on the company’s claim to reverse type 2 diabetes with the keto diet. However, some experts have raised concerns about the company’s claim to reverse diabetes with the keto diet.

Diabetes Drug Shows Promise in Reducing the Risk of Gout

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, such as canagliflozin, dapagliflozin, and empagliflozin, could play a key role in reducing the risk of gout in people with type 2 diabetes and other metabolic conditions. Researchers found that these diabetes drugs could get rid of excess uric acid from the body.